Foresite Capital | Activity | F4

Foresite Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Podcast

Jim Tananbaum appeared on 'How America Makes Medicine' podcast episode 5 discussing how VC backed America's biotech engine

How Venture Capital Backed America's Biotech Engine

Foresite Capital

youtube.com

Added recently

News

Foresite Capital named to TIME's America's Top Venture Capital Firms list for 2026

America's Top Venture Capital Firms 2026

Foresite Capital

time.com

Added recently

Investment

Foresite Capital participated in Thyme Care's Series E round

Thyme Care

Thyme Care Foresite Capital

tracxn.comSEP 2, 2026

SEP 2, 2026

Investment

Foresite Capital participated in Khartis Therapeutics' $50M Series B funding round

Khartis Therapeutics

Khartis Therapeutics Foresite Capital

finsmes.comAUG 13, 2026

AUG 13, 2026

Milestone

Parabilis Medicines, a Foresite Capital portfolio company, went public on NASDAQ

Parabilis Medicines

Parabilis Medicines Foresite Capital

tracxn.comJUN 10, 2026

JUN 10, 2026

3 investments· FEB 2026 – JUN 2026Show all

Investment

Participated as a new investor in Stepful's $55M Series C, led by Oak HC/FT, to expand its AI-powered healthcare workforce training platform.

Stepful

Stepful Foresite Capital

mobihealthnews.comJUN 2026

finsmes.com

JUN 2026

Investment

Co-led Pinnacle Medicines' oversubscribed $89M Series B alongside LAV to advance its oral peptide therapeutics pipeline.

Pinnacle Medicines

Pinnacle Medicines Foresite Capital

prnewswire.comMAR 26, 2026

MAR 26, 2026

Investment

Co-led Slate Medicines' $130M Series A financing to advance anti-PACAP therapies for migraine prevention.

Slate Medicines

Slate Medicines Foresite Capital

businesswire.comFEB 24, 2026

FEB 24, 2026

Press

Jim Tananbaum and Michael Rome gave a wide-ranging interview to GEN Edge on Foresite's 15th anniversary, discussing the firm's approach, Foresite Labs, AI drug discovery, and the biotech market outlook

On Its 15th Anniversary, Foresite Capital Looks Ahead (GEN Edge)

Foresite Capital

genengnews.comFEB 18, 2026

FEB 18, 2026

Milestone

Eikon Therapeutics, a Foresite Capital portfolio company, went public with a $381M IPO

Eikon Therapeutics

Eikon Therapeutics Foresite Capital

genengnews.comFEB 1, 2026

FEB 1, 2026

News

Named to TIME's list of America's Top Venture Capital Firms for 2025.

TIME America's Top Venture Capital Firms 2025

Foresite Capital

time.comAUG 28, 2025

AUG 28, 2025

New Fund

Closed Fund VI, a $900M vehicle to back roughly 20 healthcare and life-science companies across all stages.

Fund VI

Foresite Capital

fiercebiotech.comJUN 12, 2024

JUN 12, 2024

Investment

Co-founded and backed the $1B launch of Xaira Therapeutics, an AI-driven drug discovery company, alongside ARCH Venture Partners.

Xaira Therapeutics

Xaira Therapeutics Foresite Capital

techcrunch.comAPR 24, 2024

APR 24, 2024